# Bristol-Myers Squibb Company (BMY) — Q1-2010 Earnings Results

**Report date:** 2010-04-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2010

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 4.23%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.56 | N/A | +8.74% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed satisfaction with the EPS results, highlighting the strength of their product pipeline. They remain focused on future growth opportunities.

**Key quotes:**

> The company is pleased with the EPS performance this quarter.

> Management emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance exceeded expectations, contributing to a 4.23% increase in stock price. Investors reacted positively to the earnings beat, although no revenue figures or future guidance were shared. The company remains focused on its product pipeline, which may drive future growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2010_